Physician profile
Gregory Narzikul
NPI 1770698185
$3,587.11
in general payments reported to CMS, 2019-2025
39 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $92.37 · 2021: $43.18 · 2022: $477 · 2023: $964 · 2024: $556 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,699.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $547.60 | 2022-2025 | |
| Lilly USA, LLC | $388.89 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $320.59 | 2022-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Astrazeneca Pharmaceuticals Lp | $299.02 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $241.37 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.44 | 2019-2025 | Jardiance |
| Pfizer INC. | $162.39 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $129.59 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Exact Sciences Corporation | $106.36 | 2023-2025 | Cologuard Collection Kit |
| Corium, LLC | $90.97 | 2022-2024 | Azstarys |
| Seqirus USA INC | $88.32 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Teva Pharmaceuticals USA, INC. | $87.58 | 2023-2025 | Austedo Xr, Austedo Xr |
| Abbott Laboratories | $80.61 | 2022-2025 | Freestyle Libre 3 |
| Bausch Health US, LLC | $70.59 | 2019-2023 | Aplenzin, Wellbutrin |
| Amarin Pharma, INC. | $64.33 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Narzikul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.